| Affiliation: | 1. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA;2. INSERM, U978, Université Paris 13, Bobigny, France;3. Laboratoire d''Hématologie, APHP Hôpital Avicenne, Bobigny, France;4. Harvard Medical School, Boston, MA, USA;5. Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA;6. Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland;7. Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA;8. Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA;9. Broad Institute of MIT and Harvard, Cambridge, MA, USA;10. Department of Academic Haematology, University College London, London, UK;11. Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA;12. Department of Leukemia, the University of Texas MD Anderson Cancer Center, Houston, TX, USA;13. Department of Pathology, Brigham and Women''s Hospital, Boston, MA, USA;14. Center for Immuno-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA;15. Moores Cancer Center, University of California, San Diego, USA;16. Cutaneous Biology Research Center, Massachusetts General Hospital, Charlestown, MA, USA;17. Center for Cancer Research, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA;18. Department of Systems Biology, Beckman Research Institute, City of Hope National Comprehensive Cancer Center, Monrovia, CA, USA;19. Division of Hematology-Oncology, Department of Medicine, Moores Cancer Center, University of California, San Diego, USA;20. Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA;21. Department of Pathology, Brigham and Women''s Hospital, Boston, MA, USA;22. Department of Medicine, Brigham and Women''s Hospital, Boston, MA, USA |
